Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

₹ 2,601 1.10%
28 Mar - close price
About

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]

It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

Key Points

Product Offerings
The company manufactures pharmaceutical products under various dosage forms such as oral solids, oral liquids, topicals, suppositories, Human insulin and synthetic APIs. API manufacturing is predominantly aimed at captive consumption.[1]

  • Market Cap 88,012 Cr.
  • Current Price 2,601
  • High / Low 2,746 / 1,523
  • Stock P/E 75.5
  • Book Value 203
  • Dividend Yield 0.85 %
  • ROCE 17.7 %
  • ROE 16.0 %
  • Face Value 5.00

Pros

  • Company has been maintaining a healthy dividend payout of 68.3%

Cons

  • Stock is trading at 12.8 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
1,616 1,468 1,695 1,799 1,588 1,662 1,933 1,928 1,915 1,920 2,121 2,146 2,123
1,046 1,037 1,117 1,182 1,161 1,179 1,268 1,308 1,312 1,342 1,384 1,410 1,422
Operating Profit 570 431 578 617 427 483 665 620 603 578 737 736 701
OPM % 35% 29% 34% 34% 27% 29% 34% 32% 31% 30% 35% 34% 33%
11 91 50 54 37 61 29 11 15 26 11 15 -11
Interest 87 69 66 64 57 52 51 62 91 94 90 77 69
Depreciation 155 152 150 153 152 147 149 156 185 182 183 192 191
Profit before tax 339 301 412 454 255 345 494 413 342 328 475 482 430
Tax % 18% 7% 34% 28% 33% 36% 34% 34% 32% 33% 32% 32% 31%
278 279 274 326 170 221 327 272 234 219 323 327 297
EPS in Rs 8.22 8.24 8.10 9.63 5.02 6.53 9.66 8.04 6.91 6.47 9.54 9.66 8.78
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
2,071 2,760 3,358 3,468 5,439 4,551 4,244 5,762 6,168 6,451 6,742 7,695 8,310
1,669 2,076 2,294 2,624 2,990 3,424 3,337 4,149 4,251 4,259 4,642 5,230 5,558
Operating Profit 402 684 1,065 843 2,450 1,127 907 1,613 1,917 2,192 2,101 2,465 2,752
OPM % 19% 25% 32% 24% 45% 25% 21% 28% 31% 34% 31% 32% 33%
72 89 32 306 292 300 332 382 237 118 204 82 41
Interest 40 37 58 173 180 202 294 481 430 334 236 298 330
Depreciation 64 72 79 180 213 269 384 579 607 610 602 672 748
Profit before tax 371 665 958 796 2,348 955 562 935 1,117 1,366 1,466 1,577 1,715
Tax % 16% 18% 20% 22% 26% 11% 14% 20% 16% 17% 32% 33%
311 546 762 623 1,743 854 482 745 939 1,138 991 1,051 1,166
EPS in Rs 9.20 16.15 22.53 18.42 51.51 25.24 14.24 22.03 27.73 33.62 29.30 31.07 34.45
Dividend Payout % 23% 36% 22% 31% 34% 28% 49% 39% 58% 52% 82% 71%
Compounded Sales Growth
10 Years: 11%
5 Years: 13%
3 Years: 8%
TTM: 12%
Compounded Profit Growth
10 Years: 6%
5 Years: 18%
3 Years: 4%
TTM: 11%
Stock Price CAGR
10 Years: 26%
5 Years: 22%
3 Years: 27%
1 Year: 69%
Return on Equity
10 Years: 20%
5 Years: 17%
3 Years: 17%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 42 42 85 85 85 85 85 85 85 85 85 169 169
Reserves 1,262 1,609 2,205 2,621 3,623 4,369 4,472 4,931 5,036 5,945 6,261 6,287 6,696
579 693 1,132 2,521 2,249 2,446 5,845 5,623 5,294 4,404 3,348 4,575 3,690
695 1,012 911 1,270 1,332 1,152 1,419 1,389 1,469 1,327 1,460 1,840 2,068
Total Liabilities 2,578 3,356 4,333 6,497 7,289 8,051 11,820 12,027 11,884 11,761 11,153 12,872 12,623
636 791 836 2,764 2,681 3,523 7,429 7,425 7,198 6,741 6,251 7,972 8,170
CWIP 27 276 508 628 984 473 447 498 536 588 568 698 235
Investments 478 190 322 434 918 936 625 486 135 314 368 361 452
1,437 2,098 2,667 2,672 2,705 3,119 3,319 3,618 4,016 4,118 3,966 3,841 3,766
Total Assets 2,578 3,356 4,333 6,497 7,289 8,051 11,820 12,027 11,884 11,761 11,153 12,872 12,623

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
396 -69 310 1,065 2,403 676 929 1,232 1,580 1,573 2,140 2,265
-142 -89 -326 -2,099 -584 -527 -4,207 -373 269 -316 -160 -2,326
-192 25 86 996 -1,326 -130 2,929 -928 -1,555 -1,581 -1,977 81
Net Cash Flow 62 -133 70 -38 493 19 -349 -69 294 -325 3 20

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 72 110 143 124 61 82 95 86 89 87 83 82
Inventory Days 178 260 253 263 299 272 425 321 336 418 344 273
Days Payable 169 168 175 212 205 144 254 138 152 142 119 104
Cash Conversion Cycle 81 202 222 175 155 209 267 269 273 364 308 251
Working Capital Days 49 100 144 120 53 120 100 51 49 159 149 116
ROCE % 26% 35% 35% 22% 44% 17% 9% 13% 14% 16% 17% 18%

Shareholding Pattern

Numbers in percentages

6 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25%
11.37% 11.65% 11.53% 11.63% 10.88% 10.80% 11.37% 12.09% 12.04% 12.85% 13.15% 14.08%
8.35% 8.42% 8.72% 8.94% 9.74% 10.01% 9.40% 8.77% 8.89% 8.22% 7.91% 7.11%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10%
9.03% 8.68% 8.50% 8.18% 8.14% 7.95% 7.87% 7.78% 7.71% 7.59% 7.59% 7.46%
No. of Shareholders 72,61664,52564,30967,20563,22962,93367,86665,23763,83161,57269,61269,117

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls